Sector: MedicalLABOPHARM INC (NASDAQ: DDSS)
Ranking History
Scan Date: | 10/27/2009 |
Sector: | Medical |
Funamental : | 239 |
Technical : | 139 |
Performance : | 264 |
Overall: | 260 |
Number of Stocks: | 306 |
Scan Date: | 10/20/2009 |
Sector: | Medical |
Funamental : | 243 |
Technical : | 16 |
Performance : | 267 |
Overall: | 213 |
Number of Stocks: | 305 |
Scan Date: | 10/15/2009 |
Sector: | Medical |
Funamental : | 245 |
Technical : | 8 |
Performance : | 244 |
Overall: | 196 |
Number of Stocks: | 305 |
Headlines
- Labopharm annonce ses résultats du troisième trimestre de l'exercice 2009
Nov 06, 2009 08:36 AM | DDS, DDSS
- Labopharm to host conference call Friday, November 6, 2009 at 10:00 a.m. (ET)
Oct 29, 2009 07:44 AM | DDS, DDSS
- Labopharm tiendra une conférence téléphonique le vendredi 6 novembre 2009 à 10 h 00 (HE)
Oct 29, 2009 07:44 AM | DDS, DDSS
- Labopharm conclut une entente avec Grunenthal pour la distribution et l'approvisionnement du tramadol-acétaminophène à deux prises quotidiennes dans un certain nombre de pays européens
Oct 08, 2009 08:12 AM | DDS, DDSS
- Labopharm completes distribution and supply agreement with Grunenthal for twice-daily tramadol-acetaminophen for a number of European countries
Oct 08, 2009 08:03 AM | DDS, DDSS
- Labopharm annonce que son fournisseur de l'IPA du trazodone a répondu aux points soulevés par la FDA au niveau de la fabrication
Oct 07, 2009 08:46 AM | DDS, DDSS
- Labopharm announces that its trazodone API supplier has resolved outstanding manufacturing issues with the FDA
Oct 07, 2009 08:46 AM | DDS, DDSS
- Labopharm reçoit un avis de soumission d'une ANDA incluant une certification au titre du paragraphe IV pour une version générique de Ryzolt(TM)
Sep 30, 2009 07:04 AM | DDS, DDSS
- Labopharm receives notice of ANDA submission with paragraph IV certification for generic of Ryzolt(TM)
Sep 30, 2009 07:01 AM | DDS, DDSS
- Labopharm to present data on its novel trazodone formulation at three upcoming international medical meetings
Sep 09, 2009 01:50 PM | DDS, DDSS
- Hercules Technology Growth Capital Announces Three Portfolio Companies That Reached Multi-Million Dollar Milestones
Oct 20, 2009 02:51 PM | CPWR, DDSS, HTGC
- Labopharm's response for novel trazodone formulation accepted by FDA as complete - Designated as Class 2 resubmission
Aug 25, 2009 04:31 PM | DDS, DDSS
- Labopharm comments on judgment in Purdue patent litigation
Aug 17, 2009 08:51 AM | DDS, DDSS
- Labopharm submits response to FDA for novel antidepressant
Aug 11, 2009 12:25 PM | DDS, DDSS
- Labopharm files New Drug Submission with Health Canada for novel antidepressant
Aug 05, 2009 07:01 AM | DDS, DDSS
- Labopharm to present at Canaccord Adams 29th Annual Global Growth Conference
Jul 30, 2009 07:00 AM | DDS, DDSS
- Labopharm to host conference call Friday, August 7, 2009 at 8:30 a.m. (ET)
Jul 27, 2009 07:00 AM | DDS, DDSS
- InvestorSoup.com Issues Trading Outlook for Labopharm Inc.
Jul 22, 2009 06:51 AM | BVF, DDSS, DEPO, IPXL, WPI
- Labopharm receives complete response letter from the U.S. FDA for novel antidepressant
Jul 20, 2009 09:25 AM | DDS, DDSS
- Labopharm amends debt facility agreement with Hercules
Jun 25, 2009 07:00 AM | DDS, DDSS
Analyst Ratings
Sentiment Survey
|
|
|
|
|
|
|
|
|
|
|
Share Performance
|
Period
|
DDSS
|
Compare to S&P
|
| YTD |
-14.84 %
|
-25.76 %
|
| 4 Weeks |
11.51 %
|
10.33 %
|
| 12 Weeks |
-16.22 %
|
-18.30 %
|
|
Financial Ratios
Earnings Performance
|
EPS Growth in Last Quarter: 33.33 %
|
|
EPS Growth in Last Year: -0.01 %
|
|
Sales Growth in Last Quarter: 38.64 %
|
|
Sales Growth in Last Quarter: 20.02 %
|
|
